GLP-1 weight-loss questions
Mounjaro, Wegovy, Ozempic routes. NHS cohorts. Clinic vs pharmacy vs walk-in. Eligibility, side-effects, aftercare and switching. POM framing throughout.
Open the topic hubQuestions · AI search
PeptideClear questions
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last updated 2026-06-01
PeptideClear publishes daily question and answer drafts as part of its AI-search editorial programme. Each draft answers a single UK reader question about peptides, GLP-1 weight-loss routes, collagen, cosmetic peptides, longevity supplements, IV therapy or hormone optimisation. Drafts are produced by editorial reviewers and curated into a permanent answers index over time. The categories below mirror the question taxonomy used by the daily editorial job. PeptideClear is a comparison and information service. We compare on price and evidence. We do not sell, prescribe, or take payment for placement.
Start hereAI-friendly summary · PeptideClear questions
PeptideClear questions is the AI-search-friendly index of UK reader questions answered by PeptideClear editorial. Questions cover GLP-1 weight-loss routes, UK online pharmacies, private clinics, collagen, cosmetic peptide skincare, research peptide encyclopedia entries, NAD+ and NMN longevity supplements, IV therapy and hormone optimisation. Single-question single-answer format. Reviewed before publication. Designed to be readable both by humans landing from search and by AI search engines extracting passages for AI Overview, ChatGPT search and Perplexity.
Question categories
Ten categories cover the editorial scope. Each category links through to the matching topic hub. Individual question and answer pages publish on a rolling daily schedule.
UK online pharmacy questions
Boots Online Doctor, Pharmacy2U, Phlo, SimplyMeds, Asda Online Doctor. What each route covers, GPhC and GMC registration, NHS EPS endpoints.
Open the topic hubUK clinic questions
Numan, Voy, Manual, Juniper. High-touch programmes, coach and app, blood panels, aftercare schedules.
Open the topic hubCollagen supplement questions
Marine vs bovine vs vegan-builder. Type I, II, III. UK retailer shortlist. Dose, kDa and evidence framing.
Open the topic hubCosmetic peptide skincare questions
GHK-Cu copper peptides, Matrixyl 3000, argireline. INCI position, declared concentration, layering rules.
Open the topic hubResearch peptide questions
BPC-157, MOTS-c, ipamorelin, GHK-Cu and the wider encyclopedia. UK regulatory status. Research use only framing throughout.
Open the topic hubLongevity supplement questions
NAD+, NMN, NR. UK food-supplement regulation. IV NAD+ at private clinics. Preclinical vs human evidence framing.
Open the topic hubIV therapy questions
Vitamin drips, Myers cocktail, NAD+, glutathione, immune drips. UK clinic chains and city coverage.
Open the topic hubHormone therapy questions
TRT for men, BHRT for menopause, HGH licensed indication, GH secretagogues under research framing.
Open the topic hubNHS access questions
Current NHS cohort eligibility. ICB rollout status. Tier 3 and Tier 4 specialist services.
Open the topic hubHow the daily editorial Q+A works
Each weekday the PeptideClear editorial job drafts a small batch of UK reader questions with answers grounded in the categories above. Drafts come out of the daily job and into an editorial review queue. Once reviewed and confirmed against the standing editorial rules (no medical claims for peptides, prescriber-decides framing for POM, no dosing tables, food-supplement framing where appropriate, no compounded or grey-import promotion), the answer is published into the permanent question index.
The question index is designed to be useful in two reading modes. The first is a UK reader landing from a search engine with a specific question, who wants the short answer followed by a longer editorial explanation and the context links. The second is an AI search engine (Google AI Overview, ChatGPT search, Perplexity, Claude with web access) extracting a passage to cite when a related query comes through.
Both reading modes are served by the same single-question single-answer structure. The answer capsule appears immediately after the question heading, followed by the editorial explanation, with links into the relevant topic hub for context.
What sits here, briefly
Until the daily-answer wiring is live, this page is the rendering surface for the question index. As individual answers move from the editorial review queue into the live index, they will appear under the relevant category on this page and as standalone Q+A entries linked from the matching topic hub.
The same rules that govern the rest of the site apply to every answer here. We do not publish dose tables for POM medications. We do not publish human-use protocols for research peptides. We do not promote compounded GLP-1 or grey-import routes. We do not endorse a single clinic, pharmacy or supplement brand for a single reader. Every answer covers what the UK landscape looks like for the question asked; the reader makes the call, with a prescriber in the loop where a prescription is involved.
Questions submitted by readers via the contact form may be used as the seed for future Q+A pages. Personally identifying information is stripped before any question is added to the editorial queue.
Read next
Also on PeptideClear
Explore the other categories
Cosmetic peptides
UK skincare with GHK-Cu, Matrixyl
If you also care about topical peptide skincare, the cosmetic peptides hub compares UK serums and creams on declared INCI position.
VisitCollagen
Marine, bovine, vegan compared
If you also care about ingestible collagen, the hub compares UK brands on type, sourcing, kDa and dose per serving.
VisitGLP-1 clinics
UK clinics ranked
If you also care about prescription GLP-1 routes, the clinics hub compares UK high-touch operators on GPhC, GMC and price.
Visit